Literature DB >> 12184051

Hypertension: a microvascular and tubulointerstitial disease.

Richard J Johnson1, Bernardo Rodríguez-Iturbe, George F Schreiner, Jaime Herrera-Acosta.   

Abstract

The vast majority of patients with essential hypertension have structural changes in their kidneys consisting of preglomerular vascular disease ('arteriolosclerosis') and tubulointerstitial injury. Most authorities have assumed that these structural changes occur secondary to hypertensive renal injury. However, Goldblatt proposed that primary renal microvascular disease might be the cause of some forms of hypertension. In this paper we present recent studies from our group that support a role for both preglomerular vascular disease as well as the tubulointerstitial inflammatory response in mediating salt-sensitivity. We propose that subtle acquired renal injury may underlie the etiology of some forms of salt-sensitive hypertension.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12184051

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  7 in total

Review 1.  Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity.

Authors:  Alejandro R Chade; John E Hall
Journal:  Am J Nephrol       Date:  2016-10-22       Impact factor: 3.754

Review 2.  Uric acid and hypertension.

Authors:  Daniel I Feig; Duk-Hee Kang; Takahiko Nakagawa; Marilda Mazzali; Richard J Johnson
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

Review 3.  Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Authors:  Alejandro R Chade; Nicholas Stewart
Journal:  J Am Soc Hypertens       Date:  2013-02-19

4.  Hyperuricemia in childhood primary hypertension.

Authors:  Daniel I Feig; Richard J Johnson
Journal:  Hypertension       Date:  2003-08-04       Impact factor: 10.190

5.  Kidney pathology precedes and predicts the pathological cascade of cerebrovascular lesions in stroke prone rats.

Authors:  Stefanie Schreiber; Celine Z Bueche; Cornelia Garz; Siegfried Kropf; Doerthe Kuester; Kerstin Amann; Hans-Jochen Heinze; Michael Goertler; Klaus G Reymann; Holger Braun
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

6.  VEGF: Potential therapy for renal regeneration.

Authors:  Alejandro R Chade
Journal:  F1000 Med Rep       Date:  2012-01-03

7.  Serum uric acid in new and recent onset primary hypertension.

Authors:  N N Anand; V Padma; Arun Prasad; Krishna Chaitanya Alam; M S A Syed Mohammed Javid
Journal:  J Pharm Bioallied Sci       Date:  2015-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.